about
Stabilization of high-risk plaquesDiabetes Mellitus, Arterial Wall, and Cardiovascular Risk AssessmentMetabolic Flexibility and Dysfunction in Cardiovascular CellsAnimal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesAnti-inflammatory therapy in chronic disease: challenges and opportunitiesNew opportunities: harnessing induced pluripotency for discovery in diabetes and metabolismMechanisms of sudden cardiac death: oxidants and metabolismCardioprotective Signature of Short-Term Caloric RestrictionExtracts of Magnolia Species-Induced Prevention of Diabetic Complications: A Brief ReviewCyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitusRestless legs syndrome and cardiovascular disease: a research roadmap.Recent insights into the cellular biology of atherosclerosisAssociation of insulin resistance and coronary artery remodeling: an intravascular ultrasound study.Testing the role of myeloid cell glucose flux in inflammation and atherosclerosisDeficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease.Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.Diabetes and cardiovascular disease in older adults: current status and future directions.Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practiceCommon therapeutic targets in cardiometabolic diseaseProprotein convertases in high-density lipoprotein metabolism.Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide.Effect of fish oil supplementation on fasting vascular endothelial function in humans: a meta-analysis of randomized controlled trialsmiR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling.Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.Brown adipose tissue and thermogenesis.Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway.Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis.Differential regulation of human aortic smooth muscle cell proliferation by monocyte-derived macrophages from diabetic patients.Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA.Whole-body and hepatic insulin resistance in obese childrenGal-geun-dang-gwi-tang improves diabetic vascular complication in apolipoprotein E KO mice fed a western diet.Food restriction by intermittent fasting induces diabetes and obesity and aggravates spontaneous atherosclerosis development in hypercholesterolaemic mice.Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs.Metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score.Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cellsHematopoietic Akt2 deficiency attenuates the progression of atherosclerosis.PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program.
P2860
Q26738584-5FC241A5-DE11-438E-A155-4F1232A13EE6Q26767215-77393747-1FC7-44EA-94ED-A9748A51737AQ26796679-3DB42BEA-9837-4255-B433-64B64057F70EQ26822630-E60B9B55-98EC-4568-97B8-8C1BAB47EBDEQ26860162-7D560898-7DAB-4B01-9DFC-4B418FCD0AC8Q26995562-13403302-6874-4AE2-83EC-D1295FF10AD3Q27024176-29AF96F9-1D01-4481-AD8B-4546D478681DQ27303840-9E8CB07E-0E3F-4A59-913F-EA62179DAC62Q28073215-0233A5E8-0957-449D-9184-6CB678F8C324Q28822277-0C5D1E57-9B43-4463-B13D-3667331EA59CQ30239115-0052BE42-695F-4E83-8C99-E4DA3F63D4B1Q30300194-1AE41979-4B32-4E62-B493-AC492BB4A43CQ30408893-EF8587E3-22D7-4ECC-B3A4-65E386BE6F20Q33612986-3DF7EBF7-219C-4337-AA34-FBABA758C531Q33619351-D0F6AB79-CAF9-48BC-A7C6-449E92BA1550Q33706621-8670D2C6-F50C-4DF9-8E0D-C08A6D96C033Q33916015-1BF744B8-2269-4FBB-BEE1-350844E71AB0Q33916086-20D9A4FC-22B6-4676-A11B-E80531F3B5B5Q33959789-8DE663F6-878A-44B7-921B-9CD8931456E2Q34062993-47980C98-A856-4B22-96BF-5F31C20B66CBQ34251343-14701CA1-F21F-4602-9BD9-D3DE1CA533CEQ34256139-AFD37CA3-F817-48C0-ABA7-1E4936EEB94DQ34269858-2F985B61-F895-4093-A187-B72EB301ACBAQ34303361-B930EEB2-BB89-43FB-8B73-EBEA9A955663Q34324735-776F22C8-26B0-48AA-969E-77EEF96576F5Q34387308-91A731AD-5C6A-40DD-81FD-698FA1D459C4Q34399952-500A369D-9034-4F46-B71E-D5598BB90279Q34447547-E76B9FA9-6C2D-46CB-8ECA-C91221B309B1Q34520634-10B2D8F7-DB10-4399-8C93-DE5B39CCE1E1Q34540366-05F626F3-E730-47B9-911C-217ABD948A72Q34542793-7C76F3E6-8877-4F96-A1DA-A5371E15D152Q34545552-5B19234D-C053-49DF-A9A6-B314BC76044EQ34550127-4BC13C64-946D-46D6-8DB1-E5B5CAE2D405Q34586914-5BBAAE1C-5C2A-4334-B66C-7F8321D21F45Q34657083-69DEB433-BC65-4639-9EC2-E919B3F751C5Q34795007-F5F2E926-8B8E-4DB6-8D50-E306E0B8A8E2Q34948205-44374DE2-AACC-4D1A-86D3-C7857D952FA5Q35034843-E269D26B-85F9-43E6-B759-5934377AA8FAQ35039330-2998E52F-90F5-4FEF-B8E9-63070EF322F6Q35052658-D210ABDD-76AD-4042-A0BE-AD5B2F9A1D25
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Insulin resistance, hyperglycemia, and atherosclerosis
@ast
Insulin resistance, hyperglycemia, and atherosclerosis
@en
Insulin resistance, hyperglycemia, and atherosclerosis
@nl
type
label
Insulin resistance, hyperglycemia, and atherosclerosis
@ast
Insulin resistance, hyperglycemia, and atherosclerosis
@en
Insulin resistance, hyperglycemia, and atherosclerosis
@nl
prefLabel
Insulin resistance, hyperglycemia, and atherosclerosis
@ast
Insulin resistance, hyperglycemia, and atherosclerosis
@en
Insulin resistance, hyperglycemia, and atherosclerosis
@nl
P2860
P921
P3181
P1433
P1476
Insulin resistance, hyperglycemia, and atherosclerosis
@en
P2093
Karin E. Bornfeldt
P2860
P304
P3181
P356
10.1016/J.CMET.2011.07.015
P407
P577
2011-11-02T00:00:00Z